Development History
BSBE 19 YEARS
Milestones
2001
BSBE was formally established
2002
Self-branded ‘GCELL’ kits launched to the market
2004
Through ISO13485 by TUV
2008
HCY was selected to China Torch Program
Obtained patents from State Intellectual Property Office of the P.R.C
Expansion into overseas market
2009
The global No.1 liquid K, Na which is self-developed by BSBE launched to the market successfully
Established laboratory of molecular biology, it symbolized the key raw materials can be self-developed
2010
‘GCELL’ branded multi-bio calibrator and multi-bio control launched to the market
2011
Supported 863 Project (Subjects: cardiovascular, nutrition)
2013
Signed strategic cooperation agreement with Abbott China
Awarded National High-tech Enterprise by China Torch Program
Seeting the values of standard of CysC
2014
Awarded ‘FORBES’ the most prospective enterprise for the 9th year
IPO and listing on GEM in Shenzhen
2016
Signed ‘Technology Transfer and License’ with Abbott
Signed strategic cooperation agreement with Roche on clinical biochemistry reagents
Facility phrase II successfully completed, the production capacity improved
2017
Acquired Beijing MDC to expand coagulation testing product line
‘FORBES’ Chinese prospective enterprise
2018
Blood typing system using the DG Gel card technology launched to the market
2019
MDC3500 Full-Automatic Coagulation Analyzer is on the market.
BSBE acquired 65.55% of MXB.